Three novel mutations in POU1F1 in Israeli patients with combined pituitary hormone deficiency

G Gat-Yablonski1, A Klar, D Hirsch

  • 1Institute for Endocrinology and Diabetes, National Center for Childhood Diabetes, Schneider Children 's Medical Center of Israel, Petah Tiqva, Israel.

Insights

Three novel POU1F1 gene mutations were identified in patients with combined pituitary hormone deficiency (CPHD). These mutations impact pituitary development and hormone production, potentially leading to truncated proteins.

Area of Science:

  • Genetics
  • Endocrinology
  • Molecular Biology

Background:

  • POU1F1 is a critical pituitary transcription factor essential for anterior pituitary development and differentiation.
  • Mutations in the POU1F1 gene are linked to combined pituitary hormone deficiency (CPHD), affecting prolactin, growth hormone, and TSH.
  • CPHD is a rare endocrine disorder characterized by deficiencies in multiple pituitary hormones.

Purpose of the Study:

  • To identify novel mutations in the POU1F1 gene in patients diagnosed with CPHD.
  • To investigate the molecular basis of CPHD in affected families.
  • To characterize the potential impact of identified mutations on POU1F1 protein function.

Main Methods:

  • Clinical and biochemical data from five CPHD patients across three families were reviewed.
  • DNA analysis involved polymerase chain reaction (PCR), denaturing gradient gel electrophoresis (DGGE), and gene sequencing.
  • Genetic analysis focused on identifying variations within the POU1F1 gene.

Main Results:

  • Three previously unreported mutations in the POU1F1 gene were discovered: W193X, Q242R (-2 bp), and F262L.
  • The W193X mutation is a missense mutation, while Q242R involves a two-base pair deletion.
  • The F262L mutation is located within the POU homeodomain of the POU1F1 protein.

Conclusions:

  • Novel POU1F1 mutations were identified in Israeli CPHD patients.
  • The W193X and Q242R mutations may result in truncated POU1F1 proteins lacking critical functional domains.
  • The F262L mutation's location in the POU homeodomain suggests a potential alteration in protein activity, contributing to CPHD.
Abstract

Related Concept Videos

Pleiotropy01:33

Pleiotropy

Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...